Tinnitus Lenire® Therapy

Tinnitus Lenire® Therapy
FDA approved tinnitus treatment*
We have partnered with Neuromod Devices Ltd to bring you this amazing, innovative, clinically recognized tinnitus treatment device. The treatment was proven in large-scale clinical trials and with real world patients to reduce the symptoms of tinnitus.
Lenire is a bimodal neuromodulation device for tinnitus that has been shown to reduce symptoms and improve the quality of life of people living with tinnitus. It is a non-invasive, home-use medical device with CE-mark certification for the treatment of tinnitus, provided by our highly qualified audiologist at London Hearing.
Our Chief Audiologist, Shamim Patel was one of the first audiologist to be clinically licensed in the UK to provide patients suffering with tinnitus, with the Lenire treatment in July 2021 at The Tinnitus Clinic Ltd in London.
“The Lenire treatment has been revolutionary in reducing the perception of tinnitus for many patients. There has been a significant number of patients that have demonstrated a clinically meaningful reduction in their tinnitus symptoms in the 6 month period”.

What is the Lenire® treatment and what does it involve?
Lenire uses dual-mode neuromodulation to reduce tinnitus severity by combining mild electrical stimulation of the tongue with sound delivered through headphones. This paired stimulation promotes adaptive neuroplastic changes in the brain, helping to reduce the perception of tinnitus and the brain’s tendency to monitor or focus on it.
For the treatment you are provided with:

Understanding the Technology
- 1Customised sounds are played through Bluetooth® headphones to activate the nerve involved in hearing (the auditory nerve).
- 2Mild and safe energy pulses are delivered to the surface of the tip of the tongue to activate touch nerves to the brain.
- 3The activated nerves convert the sound and the energy pulses into signals that are relayed to the brain, where over time the unique signal patterns work to reduce and soothe the perceived tinnitus experience.
Lenire®: Clinically Proven Results:
Lenire® has undergone a thorough clinical evaluation and the outcomes include:
95% of compliant TENT-A2 tinnitus clinical trial patients reported improvement when evaluated after 12 weeks.
91% of TENT-A2 participants saw sustained improvement in tinnitus severity when evaluated at 12-months post-treatment.
Lenire has shown to provide clinically significant relief from tinnitus in clinical trials involving more than 600 participants.
86.2% of treatment-compliant participants reporting improvement in their Tinnitus Handicap Inventory (THI) scores after 12 weeks
83% of clinical trial patients would recommend Lenire to treat tinnitus.
An average reduction of 20.3 THI points, representing a full-grade improvement in tinnitus severity.
A Personalised Treatment Plan Designed Around You
Every tinnitus experience is unique. That is why Lenire treatment begins with a comprehensive assessment at London Hearing.
Take the First Step Towards Tinnitus Relief
If tinnitus is affecting your quality of life, you do not have to manage it alone.
Lenire® Therapy offers a clinically recognised, FDA approved and CE-marked treatment option for suitable patients. With expert guidance from Shamim Patel, you can explore whether this innovative therapy is right for you.

